Correlation Between GlaxoSmithKline PLC and Matthews China
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Matthews China at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Matthews China into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Matthews China Dividend, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Matthews China and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Matthews China. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Matthews China.
Diversification Opportunities for GlaxoSmithKline PLC and Matthews China
-0.61 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between GlaxoSmithKline and Matthews is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Matthews China Dividend in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Matthews China Dividend and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Matthews China. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Matthews China Dividend has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Matthews China go up and down completely randomly.
Pair Corralation between GlaxoSmithKline PLC and Matthews China
Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to under-perform the Matthews China. But the stock apears to be less risky and, when comparing its historical volatility, GlaxoSmithKline PLC ADR is 1.04 times less risky than Matthews China. The stock trades about -0.28 of its potential returns per unit of risk. The Matthews China Dividend is currently generating about -0.2 of returns per unit of risk over similar time horizon. If you would invest 1,239 in Matthews China Dividend on August 26, 2024 and sell it today you would lose (80.00) from holding Matthews China Dividend or give up 6.46% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
GlaxoSmithKline PLC ADR vs. Matthews China Dividend
Performance |
| Timeline |
| GlaxoSmithKline PLC ADR |
| Matthews China Dividend |
GlaxoSmithKline PLC and Matthews China Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with GlaxoSmithKline PLC and Matthews China
The main advantage of trading using opposite GlaxoSmithKline PLC and Matthews China positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Matthews China can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Matthews China will offset losses from the drop in Matthews China's long position.| GlaxoSmithKline PLC vs. Novartis AG ADR | GlaxoSmithKline PLC vs. AstraZeneca PLC ADR | GlaxoSmithKline PLC vs. Roche Holding Ltd | GlaxoSmithKline PLC vs. Bristol Myers Squibb |
| Matthews China vs. Fidelity China Region | Matthews China vs. Fidelity China Region | Matthews China vs. Matthews China Fund | Matthews China vs. Matthews China Small |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |